A Multicenter Randomized Controlled Study of Contrast-enhanced US versus US-guided Biopsy of Focal Liver Lesions
Wei Wu, Xiang Jing, Gai-Qin Xue, Xiaolin Zhu, Jing Wang, Rui-qing Du, Bin Lv, Ke-feng Wang, Jiping Yan, Zhong-Yi Zhang, Man-di Li, Yuko Kono, Kun Yan
Abstract
= .63). Conclusion Contrast-enhanced US-guided biopsy of focal liver lesions is an effective and safe procedure with a higher diagnostic accuracy than US-guided biopsy, especially for lesions smaller than 2.0 cm and for hepatocellular carcinoma diagnosis. Clinical trial registration no. NCT02413437 © RSNA, 2022
Topics & Concepts
MedicineBiopsyRadiologyContrast-enhanced ultrasoundPercutaneousProspective cohort studyDiagnostic accuracyClinical endpointLiver biopsyRandomized controlled trialUltrasoundSurgeryHepatocellular Carcinoma Treatment and PrognosisHepatitis B Virus StudiesLiver Disease Diagnosis and Treatment